GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cessatech AS (XSAT:CESSA) » Definitions » Institutional Ownership

Cessatech AS (XSAT:CESSA) Institutional Ownership : 0.09% (As of Sep. 21, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Cessatech AS Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cessatech AS's institutional ownership is 0.09%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cessatech AS's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cessatech AS's Float Percentage Of Total Shares Outstanding is 0.00%.


Cessatech AS Institutional Ownership Historical Data

The historical data trend for Cessatech AS's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cessatech AS Institutional Ownership Chart

Cessatech AS Historical Data

The historical data trend for Cessatech AS can be seen below:

2023-03-31 2023-04-30 2023-05-31 2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31
Institutional Ownership 2.39 2.39 2.39 2.22 1.92 1.74 0.86 0.52 0.34 0.09

Cessatech AS Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Cessatech AS Business Description

Traded in Other Exchanges
Address
Kanonbadsvej 2, Copenhagen, DNK, 1437
Cessatech AS is a pharmaceutical company committed to developing and commercializing evidence-based and innovative medicines for children for the treatment of paediatric acute pain. Its lead asset (CT001) is an analgesic nasal spray for the treatment of acute and planned painful procedures in children.

Cessatech AS Headlines

No Headlines